An Open-labelled, Multicentered, Follow-up Study for a Phase III, Efficacy Trial to Evaluate the Two-year Efficacy, Safety, and Immune Persisitence of Inactivated Enterovirus Type 71 (EV71) Vaccine

Trial Profile

An Open-labelled, Multicentered, Follow-up Study for a Phase III, Efficacy Trial to Evaluate the Two-year Efficacy, Safety, and Immune Persisitence of Inactivated Enterovirus Type 71 (EV71) Vaccine

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 May 2015

At a glance

  • Drugs Enterovirus A vaccine (Primary)
  • Indications Coxsackievirus infections; Enterovirus A infections
  • Focus Therapeutic Use
  • Sponsors Sinovac Biotech
  • Most Recent Events

    • 21 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 10 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top